For some people, GLP-1 agonists might be the exact thing they need to help them in their weight loss journey where nothing else has worked
Most require a BMI of 30 or higher, obesity-related conditions, and prior authorization
0.47 oz / 14 ml
It stands out from other peptides because of the wide variety of biological areas it has been studied in, ranging from muscle to connective tissue to gastrointestinal environments
Consistent with other diseases, there are clear disparities between patient experiences and physician perceptions, with a clear need to improve gaps in physician-patient communication with regard to GLP-1 therapeutics and incidence of illness
Developed by a multidisciplinary team of dietitians, public health nutritionists, and food technology experts, it offers an evidence-based roadmap for supporting GLP-1 therapy